• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

No current evidence supporting risk of using Ibuprofen in patients with COVID-19.

作者信息

Martins-Filho Paulo Ricardo, do Nascimento-Júnior Edmundo Marques, Santos Victor Santana

机构信息

Investigative Pathology Laboratory, Federal University of Sergipe, Brazil.

Centre for Epidemiology and Public Health, Federal University of Alagoas, Arapiraca, Brazil.

出版信息

Int J Clin Pract. 2020 Oct;74(10):e13576. doi: 10.1111/ijcp.13576.

DOI:10.1111/ijcp.13576
PMID:32506743
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7300561/
Abstract
摘要

相似文献

1
No current evidence supporting risk of using Ibuprofen in patients with COVID-19.目前没有证据支持新冠病毒肺炎患者使用布洛芬存在风险。
Int J Clin Pract. 2020 Oct;74(10):e13576. doi: 10.1111/ijcp.13576.
2
COVID-19 and Avoiding Ibuprofen. How Good Is the Evidence?COVID-19 和避免使用布洛芬。证据有多好？
Am J Ther. 2020 Jul/Aug;27(4):e400-e402. doi: 10.1097/MJT.0000000000001196.
3
NSAIDs for analgesia in the era of COVID-19.COVID-19 疫情时期的 NSAIDs 类药物用于镇痛。
Reg Anesth Pain Med. 2020 Sep;45(9):677-678. doi: 10.1136/rapm-2020-101584. Epub 2020 Jun 3.
4
Does Ibuprofen Worsen COVID-19?布洛芬会加重新型冠状病毒肺炎病情吗？
Drug Saf. 2020 Jul;43(7):611-614. doi: 10.1007/s40264-020-00953-0.
5
Rapid Review: Nonsteroidal Anti-inflammatory Agents and Aminosalicylates in COVID-19 Infections.快速综述：非甾体抗炎药和氨基水杨酸盐在 COVID-19 感染中的作用。
J Clin Gastroenterol. 2020 Aug;54(7):602-605. doi: 10.1097/MCG.0000000000001371.
6
Could patients taking isotretinoin therapy be immune against SARS-CoV-2?正在接受异维甲酸治疗的患者对SARS-CoV-2有免疫力吗？
Dermatol Ther. 2020 Jul;33(4):e13573. doi: 10.1111/dth.13573. Epub 2020 May 29.
7
Warning Against the Use of Anti-Inflammatory Medicines to Cure COVID-19: Building Castles in the Air.警告：切勿使用抗炎药物治疗新冠病毒病：此举无异于空中楼阁。
Adv Ther. 2020 May;37(5):1705-1707. doi: 10.1007/s12325-020-01321-1. Epub 2020 Apr 1.
8
Age but not sex may explain the negative effect of arterial hypertension and diabetes on COVID-19 prognosis.年龄而非性别可能解释动脉高血压和糖尿病对新冠病毒疾病预后的负面影响。
J Infect. 2020 Oct;81(4):647-679. doi: 10.1016/j.jinf.2020.05.010. Epub 2020 May 11.
9
Antihypertensive drugs and risk of COVID-19?抗高血压药物与新冠病毒病风险？
Lancet Respir Med. 2020 May;8(5):e30-e31. doi: 10.1016/S2213-2600(20)30153-3. Epub 2020 Mar 26.
10
Antihypertensive drugs and risk of COVID-19?抗高血压药物与新型冠状病毒肺炎风险？
Lancet Respir Med. 2020 May;8(5):e29. doi: 10.1016/S2213-2600(20)30156-9. Epub 2020 Mar 26.

引用本文的文献

1
COVID-19 Management in the Pediatric Age: Consensus Document of the COVID-19 Working Group in Paediatrics of the Emilia-Romagna Region (RE-CO-Ped), Italy.儿童时期 COVID-19 的管理：意大利艾米利亚-罗马涅地区（RE-CO-Ped）儿科 COVID-19 工作组的共识文件。
Int J Environ Res Public Health. 2021 Apr 8;18(8):3919. doi: 10.3390/ijerph18083919.
2
A computational approach to aid clinicians in selecting anti-viral drugs for COVID-19 trials.一种计算方法，帮助临床医生在 COVID-19 试验中选择抗病毒药物。
Sci Rep. 2021 Apr 27;11(1):9047. doi: 10.1038/s41598-021-88153-3.
3
Clinical Management of Hypertension, Inflammation and Thrombosis in Hospitalized COVID-19 Patients: Impact on Survival and Concerns.住院COVID-19患者高血压、炎症和血栓形成的临床管理：对生存的影响及关注点
J Clin Med. 2021 Mar 4;10(5):1073. doi: 10.3390/jcm10051073.
4
Challenges and Opportunities from Targeting Inflammatory Responses to SARS-CoV-2 Infection: A Narrative Review.靶向SARS-CoV-2感染炎症反应的挑战与机遇：一篇综述
J Clin Med. 2020 Dec 12;9(12):4021. doi: 10.3390/jcm9124021.
5
Paracetamol-Induced Glutathione Consumption: Is There a Link With Severe COVID-19 Illness?对乙酰氨基酚引起的谷胱甘肽消耗：与重症 COVID-19 疾病有关联吗？
Front Pharmacol. 2020 Oct 7;11:579944. doi: 10.3389/fphar.2020.579944. eCollection 2020.

本文引用的文献

1
Safety of Ibuprofen in Patients With COVID-19: Causal or Confounded?布洛芬在新冠病毒肺炎患者中的安全性：因果关系还是混淆因素？
Chest. 2020 Jul;158(1):55-56. doi: 10.1016/j.chest.2020.03.040. Epub 2020 Mar 31.
2
Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection?高血压和糖尿病患者感染新型冠状病毒肺炎（COVID-19）的风险会增加吗？
Lancet Respir Med. 2020 Apr;8(4):e21. doi: 10.1016/S2213-2600(20)30116-8. Epub 2020 Mar 11.
3
Angiotensin receptor blockers as tentative SARS-CoV-2 therapeutics.血管紧张素受体阻滞剂可作为治疗 SARS-CoV-2 的候选药物。
Drug Dev Res. 2020 Aug;81(5):537-540. doi: 10.1002/ddr.21656. Epub 2020 Mar 4.
4
Risk factors for local complications in children with community-acquired pneumonia.社区获得性肺炎患儿局部并发症的危险因素。
Clin Respir J. 2018 Jan;12(1):253-261. doi: 10.1111/crj.12524. Epub 2016 Jul 25.
5
Ibuprofen attenuates cardiac fibrosis in streptozotocin-induced diabetic rats.布洛芬可减轻链脲佐菌素诱导的糖尿病大鼠的心脏纤维化。
Cardiology. 2015;131(2):97-106. doi: 10.1159/000375362. Epub 2015 Apr 15.
6
Prevalence and risk factors of suppurative complications in children with pneumonia.儿童肺炎化脓性并发症的患病率及危险因素。
Acta Paediatr. 2010 Jun;99(6):861-6. doi: 10.1111/j.1651-2227.2010.01734.x. Epub 2010 Feb 19.
7
Role of the renin-angiotensin system in vascular inflammation.肾素-血管紧张素系统在血管炎症中的作用。
Trends Pharmacol Sci. 2008 Jul;29(7):367-74. doi: 10.1016/j.tips.2008.05.003. Epub 2008 Jun 23.
8
The discovery of angiotensin-converting enzyme 2 and its role in acute lung injury in mice.血管紧张素转换酶2的发现及其在小鼠急性肺损伤中的作用。
Exp Physiol. 2008 May;93(5):543-8. doi: 10.1113/expphysiol.2007.040048. Epub 2008 Apr 10.
9
Inflammation and angiotensin II.炎症与血管紧张素II
Int J Biochem Cell Biol. 2003 Jun;35(6):881-900. doi: 10.1016/s1357-2725(02)00271-6.